The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
about
CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cellsRole of the tumor microenvironment in mature B-cell lymphoid malignanciesRole of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsAdvances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesPrognostic factors in hodgkin lymphomaTumor-associated macrophages and survival in classic Hodgkin's lymphoma.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphomaA Multi-Component Model of Hodgkin's Lymphoma.The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma.Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.Relapsed Hodgkin lymphoma: management strategiesRegulatory T cells and treatment of cancer.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells.Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.Predicting treatment outcome in classical Hodgkin lymphoma: genomic advancesT regulatory cells in B-cell malignancy - tumour support or kiss of death?The four types of Tregs in malignant lymphomas.Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.Regulatory T cells in allogeneic stem cell transplantation.XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma.Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion.Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T CellsGene Expression Profiling for In Silico Microdissection of Hodgkin's Lymphoma Microenvironment and Identification of Prognostic Features.T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications.Macrophages predict treatment outcome in Hodgkin's lymphomaCD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.The Dual Role of Treg in Cancer.Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma<sup/>.Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin's lymphoma.
P2860
Q24303493-87182D76-9913-4484-AD77-4358EDF7045CQ26748775-78CB8C73-CE2C-4C0C-B504-7DEF961202D5Q27011510-3B0C50AE-38D9-4F4E-A2F0-A37FD24E9B02Q33886267-B77EE55C-6C25-4E9E-8761-DE9220B243C9Q33920147-5A52E98E-F0B3-417B-AD27-977F1DB6CDD6Q33962334-568A2785-8DDA-4E01-83E7-34F8E9E9F726Q34041661-4C97AE34-9965-4A77-919A-C623AB89CE7CQ34103249-590F4E3B-EC82-422E-A9A2-AD78E68C5BE9Q35615085-FF081121-7F94-4539-8E30-6A2E5895F4C4Q35679834-E614164E-CC6E-48B3-BB28-857E3BBCF91BQ36375393-AFBADAC9-22A4-4DCA-BC2B-3800C1124A04Q37008427-0C050331-14F8-4C28-9ED9-472A74D7CF99Q37174953-89A64AAC-D7CB-4B35-9C02-50D86BE9639BQ37271829-9ACF0C5C-B2D3-401C-9F5E-0752BA7BFEC6Q37659012-E1F13EF8-D3BA-4A42-9306-E34A3EE147DFQ37680983-BBAD6179-C500-49A5-8371-967D7BA4BAE6Q37788679-90F6DD1B-02B3-4B3B-9893-E5DD3892392BQ37872044-666107BE-A893-4752-AEE8-4CCD591EA89CQ37960166-263479EC-CAF8-4EA0-B6F0-DEEE1893E2E4Q37966000-AA4A8FF9-3ADF-4EB6-9E17-AC75EB62B70DQ38068839-2EA1E2EE-70A3-4DE6-8135-15C62CB99815Q38112114-0E3AE6E6-0577-40E0-A3F0-351CDA13AACAQ38115232-A2C13349-1CAF-422C-BB1F-CB28364A7B1CQ38868904-965C5445-8879-4EAC-BBDC-0105F4183994Q39868627-C13F220A-4F5A-4EC3-9320-609ABBC4EF95Q39997121-E4F46AE6-60C0-432B-834B-09F838EFDB74Q40625940-99549C11-68C5-426B-A52D-F50B99BB230BQ41234224-6A04D6B6-4F06-46C3-BD33-0602523E337DQ42408344-8EA8FFD3-BBC5-49AD-AEC7-788402E8A09DQ42586761-F1D7DA8E-28CB-4CDB-BCCC-2ACC3CE947CBQ43727060-98069C97-C797-4DEF-BCCC-494ACD092100Q45231156-39A4BFC9-8820-4B77-8DDB-1E6DCC3F0278Q45356227-0460C5FE-F4C3-4F99-87C6-347752D64B4BQ45362166-4E2241F9-C384-46E9-AAE8-02DF3E0604E9Q47602259-400EF02C-191A-4B2A-87F6-AD97C8F06458Q47755372-83172D82-E299-4203-A60B-836C17C8BAFFQ48936220-F4425875-FEF5-4A96-9AEC-CA0C987A9993Q52645848-5BFF56DA-198F-4023-8B6F-2ADA41A57D28Q52839835-5831C960-CC1B-413F-830D-B58D6F29BC2DQ53119739-C09AD861-91ED-4F98-9D9E-D6417A1260EC
P2860
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@en
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@nl
type
label
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@en
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@nl
prefLabel
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@en
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@nl
P2093
P356
P1476
The ratio of FOXP3+ regulatory ...... t of bcl-2 and MAL expression.
@en
P2093
Brad Pohlman
Eric D Hsi
Paul Elson
Todd W Kelley
P304
P356
10.1309/NB3947K383DJ0LQ2
P407
P577
2007-12-01T00:00:00Z